Ranitidine Injection USP (2020-08-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Ranitidine Injection USP
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| JX9941 | Ranitidine Injection USP | - Recalling Firm
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| DIN 02256711 | Solution | Ranitidine (Ranitidine Hydrochloride) 25 mg/mL |
The affected lots may contain particles.
Healthcare establishments